Insufficient response to mRNA SARS-CoV-2 vaccine and high incidence of severe COVID-19 in kidney transplant recipients during pandemic

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccination may fail to sufficiently protect transplant recipients against coronavirus disease 2019 (COVID-19). We retrospectively evaluated COVID-19 in kidney transplant recipients (n = 226) after BNT162b2 mRNA vaccine administration...

Descripción completa

Detalles Bibliográficos
Autores principales: Reischig, Tomas, Kacer, Martin, Vlas, Tomas, Drenko, Petr, Kielberger, Lukas, Machova, Jana, Topolcan, Ondrej, Kucera, Radek, Kormunda, Stanislav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906453/
https://www.ncbi.nlm.nih.gov/pubmed/34860470
http://dx.doi.org/10.1111/ajt.16902

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906453/
https://www.ncbi.nlm.nih.gov/pubmed/34860470
http://dx.doi.org/10.1111/ajt.16902

Ejemplares similares